Dentsply Continues to Face Strong Headwinds in Europe

Although Dentsply’s revenue growth continues to fall slightly short our expectations, management’s ability to offset the medical device tax combined with the integration of Astra Tech kept total earnings growth near analyst’s forecasts. Excluding precious metals, Dentsply’s revenue increased 3.4%, or 2.7% on a constant currency basis, which is slightly below last year’s internal growth but on par with the second quarter. While sales growth … Continue reading Dentsply Continues to Face Strong Headwinds in Europe

Polaris Continues to Surge; Results Beat Street Estimates

Polaris continues to deliver better-than-expected results, benefiting from persistent demand in response to well-received product launches and healthy growth in recently acquired businesses. While our narrow moat is predicated on strength in the firm’s brand and traditional product categories, we believe acquisitions and expansion into adjacent businesses could act as a major catalyst for earnings over the next decade. Shares are up 54% year to … Continue reading Polaris Continues to Surge; Results Beat Street Estimates

Banco Bradesco Lowers Guidance on Slow Loan Growth

Banco Bradesco reported net income of BRL 3 billion (about $1.4 billion) for the third quarter. This was a 3.5% increase sequentially and 6.5% on a year-over-year basis. We are maintaining our narrow-moat rating and our fundamental outlook for the company at this time. Net interest income was BRL 11.7 billion, up 17% sequentially from BRL 10 billion and down 15% from BRL 13.8 billion … Continue reading Banco Bradesco Lowers Guidance on Slow Loan Growth

Quest Diagnostics Struggles Continue in Q3

Quest Diagnostics followed up its earlier release of disappointing preliminary third-quarter results with more details behind the under performance and pulled back its outlook for the full year. The addition of this information has not materially changed our assumptions and we are holding steady on our $65 fair value estimate. Despite the new management team’s well-publicized plans to improve Quest’s operations and enhance efficiencies, we … Continue reading Quest Diagnostics Struggles Continue in Q3